Cell cycle protein cyclin y is associated with human non-small-cell lung cancer proliferation and tumorigenesis

Clinical Lung Cancer

Volumn 12, Issue 1, 2011, Pages 43-50

  Yue, Wentao ^a   Zhao, Xiaoting ^a   Zhang, Lina ^a   Xu, Shaofa ^a   Liu, Zhidong ^a   Ma, Li ^a   Jia, Wenyun ^a   Qian, Zhe ^a   Zhang, Chunyan ^a   Wang, Yue ^a   Yang, Xuehui ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

CCNY; Real time RT PCR; RNA interference; siRNA

Indexed keywords

CELL CYCLE PROTEIN; CELL CYCLE PROTEIN CYCLIN Y; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFANT; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRESCHOOL CHILD; PROTEIN DEPLETION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SCHOOL CHILD; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 79551539038     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.3816/CLC.2011.n.006     Document Type: Article

References (28)

1. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest 2003;123:21S-49S.
2. Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours. Eur Respir J 2001;18:1059-68.
3. Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preop-erative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994;330:153-8.
4. Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006;6:369-81.
5. Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent ki-nases. Genes Dev 2004;18:2699-711.
6. Zhu W, Giangrande PH, Nevins JR. E2Fs link the control of G1/S and G2/M transcription. EMBO J 2004;23:4615-26.
7. Arnold A, Kim HG, Gaz RD, et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 1989;83:2034-40.
8. Schuuring E, Verhoeven E, Mooi WJ, et al. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 1992;7:355-61.
9. Gautschi O, Hugli B, Ziegler A, et al. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients. Lung Cancer 2006;51:303-11.
10. Betticher DC, Heighway J, Hasleton PS, et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 1996;73:294-300.
11. Li X, Wang X, Liu G, et al. Identification and characterization of cyclin X which activates transcriptional activities of c-Myc. Mol Biol Rep 2009;36:97-103.
12. Jiang M, Gao Y, Yang T, et al. Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1. FEBS Lett 2009;583:2171-8.
13. Zhang W, Chen Y, Wei H, et al. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin Cancer Res 2008;14:6432-9.
14. Zhang W, Glockner SC, Guo M, et al. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res 2008;68:2764-72.
15. Singhal SS, Singhal J, Yadav S, et al. Regression of lung and colon cancer xe-nografts by depleting or inhibiting RLIP76 (Ral-binding protein 1). Cancer Res 2007;67:4382-9.
16. Zhou BB, Peyton M, He B, et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell 2006;10:39-50.
17. Meyerson M, Enders GH, Wu CL, et al. A family of human cdc2-related protein kinases. EMBO J 1992;11:2909-17.
18. Gillett C, Fantl V, Smith R, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994;54:1812-7.
19. Klein EA, Assoian RK. Transcriptional regulation of the cyclin D1 gene at a glance. J Cell Sci 2008;121:3853-7.
20. Nielsen NH, Arnerlov C, Emdin SO, et al. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer 1996;74:874-80.
21. Wang A, Yoshimi N, Suzui M, et al. Different expression patterns of cyclins A, D1 and E in human colorectal cancer. J Cancer Res Clin Oncol 1996;122:122-6.
22. Sakaguchi T, Watanabe A, Sawada H, et al. Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer 1998;82:1238-43.
23. Mishina T, Dosaka-Akita H, Hommura F, et al. Cyclin E expression, a potential prognostic marker for non-small cell lung cancers. Clin Cancer Res 2000;6:11-6.
24. Fukuse T, Hirata T, Naiki H, et al. Prognostic significance of cyclin E overexpres-sion in resected non-small cell lung cancer. Cancer Res 2000;60:242-4.
25. Lonardo F, Rusch V, Langenfeld J, et al. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Cancer Res 1999;59:2470-6.
26. Xu Y, Wang Z, Wang J, et al. Lentivirus-mediated knockdown of cyclin y (CCNY) inhibits glioma cell proliferation. Oncol Res 2010;18:359-64.
27. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-7.
28. Malumbres M, Barbacid M. Cell cycle kinases in cancer. Curr Opin Genet Dev 2007;17:60-5.